Plaintiff Claims Drugmaker Knew of Actos Cancer Risk
Elise Kramer | March 20th, 2012
A plaintiff who filed a lawsuit on the 2nd of March, 2012, in the Circuit Court of Cook County, Illinois, claims that drug maker Takeda Pharmaceuticals knew of the risk of Actos bladder cancer and failed to warn patients of the potentially deadly side effect. Plaintiff Marlene Chambers filed her Actos lawsuit with the help of an Actos lawyer against the drug maker, asking for damages that would help cover medical bills and other costs associated with her injury at the hands of the diabetes medication.
The United States’ Food and Drug Administration warned in June of 2011 of the risk of Actos bladder cancer, especially in patents who take the type II diabetes medication for a year or more. Actos heart failure and limb fractures have also been noted as side effects, but Actos bladder cancer remains the most prominent side effect noted in Actos lawsuits.
Plaintiff claims Actos bladder cancer diagnosis
According to her lawsuit, Chambers began taking Actos in 2007 in order to help treat her type II diabetes. Actos helps to regulate a plaintiff’s blood sugar and therefore can be helpful in the treatment of this disease. However, she was diagnosed with Actos bladder cancer about two years later, in 2009, and claims that as a result she has suffered severe mental and physical pain and suffering as well as financial losses due to medical bills. She is suing Takeda for negligence and liability.
She and her Actos lawyer cite several studies that have linked Actos and bladder cancer, including a two-year animal study that took place before the drug was approved for the United States’ pharmaceutical market. Tumors were observed in male rats who had taken Actos, but these studies were not mimicked in humans. A 2005 study also showed a higher percentage of bladder cancer cases in patients receiving Actos as opposed to other, similar medications. A tree-year liver study produced similar results, and an ongoing study conducted by Kaiser Permanente which prompted the Food and Drug Administration’s June 2011 Actos warning.
Plaintiff claims side effects were hidden
Chambers and her Actos lawyer assert that Takeda knew of the risks associated with the medication and still hid Actos side effects from the general public in the interest of making a profit. The Food and Drug Administration’s analysis of adverse event reports filed between 2004 and 2009 showed in April of 2011 that Actos presented a “definite risk” of bladder cancer, but still Chambers claims that defendant Takeda failed to warn patients, physicians, and the medical community about the serious risk of Actos bladder cancer.
- Plaintiff Files Actos Lawsuit in Illinois
- Tennessee Plaintiff Joins Actos Litigation
- Florida Man Files Actos Bladder Cancer Lawsuit